Caribbean OTC and Consumer Healthcare Research Methodology

Over-the-counter (OTC) and consumer healthcare research occupies a unique commercial position in the Caribbean. Unlike prescription pharmaceutical research, where the buyer (physician or formulary) and end user (patient) are often distinct, OTC research must capture the full consumer journey: symptom recognition, brand awareness, shelf-discovery, pharmacist or retailer recommendation, price comparison, and repeat-purchase behavior. This crosses three commercial worlds: pharmaceutical distribution, FMCG retail, and healthcare consumer behavior.

Hope Research Group has conducted OTC and consumer healthcare studies across 21 Caribbean and Latin American markets for the last four decades. This article documents the methodology framework, covering sampling, instrument design, distribution channel coverage, regulatory navigation, and analysis, that produces commercially actionable findings for OTC brands entering, expanding in, or defending share in the region.

Why Caribbean OTC research differs from prescription pharmaceutical research

Three structural differences shape the methodology:

Distribution complexity. OTC products in the Caribbean move through pharmacies, supermarkets, convenience stores, gas station retailers, traditional grocers (colmados, parlors, mom-and-pop shops), and increasingly online platforms. A consumer health study that only covers pharmacies misses 30-50% of category volume in many markets. The methodology must explicitly map and sample across all relevant channels.

Pharmacist as gatekeeper and influencer. While OTC products do not legally require a prescription, Caribbean consumers frequently consult pharmacists for recommendations, particularly for symptoms requiring category selection (cold and flu, gastrointestinal, pain relief, skin care). Pharmacist recommendation studies are a critical component of OTC research with no equivalent in prescription research, where physicians prescribe specific molecules.

Self-medication and informal channels. Caribbean consumers commonly self-medicate using OTC products purchased without consultation, often based on family or community recommendations. Diaspora networks influence brand awareness: products consumed in the US or UK are often sought when returning home. Research instruments must capture these informal information sources alongside formal media exposure.

For the methodology foundations that apply across all Caribbean pharmaceutical research, see our Caribbean Pharma Fieldwork and Caribbean HCP Research Methodology articles. The work below focuses on what is distinctively required for OTC and consumer healthcare studies.

Market size and structure across key Caribbean markets

The Caribbean consumer healthcare market is fragmented across markets with very different demographics, GDP per capita, and retail infrastructure. Commercial planning must account for these differences rather than treating the region as homogeneous.

• Dominican Republic: The region's largest consumer healthcare market by volume. Pharmacy chains (Carol, GBC, San Judas) dominate distribution alongside thousands of independent pharmacies. Self-medication is common; pharmacist recommendation is a significant purchase driver.
• Jamaica: Mature pharmacy retail with chains (Fontana, Lloyds, Pharmacy & You) plus independents. Strong influence from US OTC brands due to remittance economy and diaspora ties.
• Trinidad and Tobago: Higher per-capita disposable income drives premium OTC penetration. SuperPharm, Carlton, and Hi-Lo Foods pharmacies dominate, with significant supermarket presence.
• Puerto Rico: Operates partly within the US FDA regulatory framework, blurring lines between OTC and prescription pharmacy market dynamics. Walgreens, CVS, and local chains drive distribution.
• Bahamas, Barbados, Cayman Islands: Smaller populations but high per-capita spending. Imports from US, UK, and Canada dominate the OTC shelf set.
• Eastern Caribbean (OECS): Antigua, Saint Lucia, Grenada, Saint Vincent, Saint Kitts, Dominica: small markets that often share OTC import dynamics and require regional pooling for research economics.
• Suriname, Guyana: Distinct regulatory and language environments (Dutch and English respectively) requiring localized instruments.

A methodology that aggregates all 21 markets into a single sample masks the variability that drives commercial decisions. Most rigorous OTC studies sample 3-6 markets selected to represent the diversity, with country-level reporting.

Defining the OTC research universe

Before fieldwork begins, the research instrument must clearly define what is being studied. The OTC universe spans a spectrum:

The traditional and natural remedies category deserves specific methodological attention. Across the Caribbean, traditional bush medicines and herbal preparations compete with formal OTC products. A market sizing study that ignores this category overstates the addressable market for branded OTC products by 15-30% in some categories (notably cold remedies, gastrointestinal, and skin care).

Sampling design for consumer healthcare studies

OTC research samples typically draw from three populations depending on study objectives:

General consumer samples (N=400-800 per market). For market sizing, awareness, attitudes, and usage (AAU) studies, brand health tracking, and concept testing. Recruitment via online panels supplemented by face-to-face intercepts to reach lower-digital-penetration segments. Quotas typically on age, sex, urban/rural, income, and household composition.

Recent category buyers (N=200-400). For brand-specific studies (purchase drivers, repeat behavior, satisfaction). Recruitment requires screening for category purchase in a relevant window (typically last 3-6 months for episodic categories, last month for routine VMS).

Pharmacy shoppers (N=300-500). For shop-along studies, exit interviews, and shopper behavior research. Recruitment in-store with appropriate retailer permissions, or via diary recruitment for planned shopping trips. Critical for understanding the moment-of-truth purchase decision that survey-based research cannot capture.

A robust OTC market entry study typically combines all three samples: general consumer for sizing and awareness, category buyers for brand dynamics, and shoppers for distribution-channel and pack-design insights.

Pharmacy audits and retail channel coverage

A pharmacy audit captures what is actually on shelves: brand presence, pack sizes, prices, promotional activity, planogram positioning, out-of-stock incidence, and pharmacist behavior. For OTC research, the audit is often more revealing than survey-claimed behavior, as consumers consistently overstate planned brand purchase and understate price-driven switching.

Hope Research Group's pharmacy audit methodology covers:

• Chain pharmacies: Sampled across geographies and store formats. Major chains audited monthly or quarterly for tracking studies.
• Independent pharmacies: Critical in markets like the Dominican Republic where independents drive significant volume. Sampling stratified by neighborhood income tier.
• Supermarket pharmacy aisles: Often missed in pharmacy-focused audits. Carry different OTC SKUs at different prices than dedicated pharmacies.
• Traditional retail (colmados, parlors, mom-and-pop): Carry a limited OTC range (typically pain relief, cold remedies, antacids). Important for sachet and single-dose pack analysis.
• Convenience and gas station retail: Growing channel, particularly in urban Trinidad, Jamaica, Bahamas.
• E-commerce: Pharmacy chain websites, marketplace listings, and informal social-commerce. Pricing and SKU availability often differ materially from physical retail.

For specifics on the audit fieldwork methodology including data capture protocols, see our Mystery Shopping Services in Jamaica article, which documents the core retail observation methodology applied across categories.

Pharmacist recommendation research

The pharmacist is a category-specific influencer in Caribbean OTC purchase. Research methodology for pharmacist recommendation typically includes:

• Pharmacist surveys (N=100-200 per market): Quantitative assessment of recommendation patterns by therapeutic category, brand awareness, and perceptions of product attributes.
• Pharmacist depth interviews (N=20-40 per market): Qualitative exploration of how recommendations are made, including the role of trade promotions, training programs, and personal experience.
• Mystery shopping with symptom presentations: Standardized symptom scenarios presented by trained shoppers to capture actual recommendation behavior rather than claimed. Particularly valuable for switching dynamics and new-product launch readiness.

Caribbean pharmacist research must navigate two specific dynamics: chain-pharmacy pharmacists often have category recommendation guidelines from corporate that constrain independent judgment, while independent pharmacy owners are themselves entrepreneurial decision-makers whose recommendations reflect personal commercial relationships with distributors and reps.

Consumer shopper research methodology

Shopper research captures behavior at the point of purchase. Three complementary methods apply:

Shop-along ethnography. Researchers accompany consumers through their actual shopping trip, observing category aisle behavior, pack-handling, label-reading, brand comparison, and purchase decisions. Particularly revealing for OTC categories where the consumer is symptomatic and time-pressured. Sample sizes typically 15-30 shop-alongs per market for qualitative depth.

Exit interviews. Brief intercept interviews with shoppers immediately after purchase, capturing what was purchased, why this brand over alternatives, price awareness, and influence of in-store factors. Sample sizes 200-400 per market for quantitative reliability.

Eye-tracking and aisle observation studies. Where commercially justified, eye-tracking technology captures actual visual attention on planograms, informing pack design, shelf positioning, and POS material effectiveness. Particularly valuable in market-leader defense studies.

The shop-along method specifically reveals patterns that survey-based research consistently misses: pack size selection rationale (often household-size driven, not value-driven as commonly assumed), color-coding navigation behavior (consumers select known color schemes when uncertain between brands), and pharmacist-direction frequency (often the actual purchase driver despite low survey-reported influence).

Therapeutic category research depth

Each major OTC category has methodology-specific considerations:

Cold, cough, flu remedies. Highly seasonal in non-tropical regions but relatively stable in Caribbean markets due to humidity-driven respiratory conditions year-round. Research design must capture multi-symptom remedy preferences vs single-symptom, a category where consumer claimed behavior often diverges from purchase data. Brand loyalty is moderate; price-driven switching is high during peak demand periods.

Pain relief and analgesics. The Caribbean OTC pain category is bifurcated between branded products (Panadol/Tylenol, Advil/Motrin, locally-known brands) and generic paracetamol/ibuprofen at significantly lower prices. Research must explicitly probe price-tier comparisons. Topical analgesics (rubs, gels) carry distinct purchase drivers tied to athletic and arthritic use cases.

Gastrointestinal (antacids, anti-diarrheals). Climate and food-safety factors drive higher Caribbean penetration vs temperate markets. Anti-diarrheal demand spikes during tourism peaks and rainy seasons. Research instruments should include traveler use, not just resident use.

Vitamins, minerals, supplements (VMS). The fastest-growing OTC segment in most Caribbean markets. Research must distinguish between multivitamins (mass market), single-nutrient supplements (often educated-consumer segments), and herbal/natural supplements (cross-pressure from traditional remedies). Diaspora-driven brand awareness is particularly strong in this category.

Skin and topical. Climate-driven categories with year-round demand. Antiseptics, antifungals, and sun care dominate volume. Research must navigate prescription/OTC switching dynamics for certain topical antifungals and corticosteroids.

For complete prescription-side research depth on Caribbean disease patterns including the OTC-adjacent areas of analgesia and gastrointestinal disease, see our Caribbean Diabetes Research Methodology and Caribbean Patient Recruitment Methodology articles, which document related prevalence data and patient sourcing methodology.

Regulatory considerations across markets

OTC regulatory frameworks vary significantly across the Caribbean and shape what research questions are commercially relevant:

• CARICOM countries: Largely independent national drug regulatory authorities. CARICOM has worked toward harmonization but national approvals remain separate. OTC scheduling can vary: a product OTC in Jamaica may require prescription in Barbados.
• Dominican Republic: DIGEMAPS regulates pharmaceutical and OTC products. The country has a substantial generic OTC manufacturing base.
• Cuba: Separate state-controlled pharmaceutical and OTC distribution.
• Puerto Rico, US Virgin Islands: Operate under US FDA regulations.
• Cayman Islands, British Virgin Islands: UK-influenced regulatory framework.
• Suriname: Dutch-influenced framework, separate language considerations.

For OTC market entry studies, the methodology should include a regulatory mapping component: confirming product status (OTC, prescription, restricted) across target markets before fieldwork begins.

Distribution channel competitive intelligence

OTC commercial planning requires understanding the distribution channel from the brand's commercial perspective: which distributors carry which manufacturer's portfolios, what trade terms are typical, what minimum order quantities and credit terms exist, and what shelf-space and promotional access can be negotiated.

This level of commercial intelligence typically requires:

• Distributor depth interviews: Conducted with senior commercial managers at major importers and distributors. Topics include category economics, brand portfolio decisions, competitive dynamics, and growth opportunities. Sample sizes 8-15 distributors per market.
• Pharmacy chain category management interviews: With buyers and category managers at chains. Topics include planogram economics, private label dynamics, and trade promotion ROI.
• Trade press and association data: Caribbean pharmacist associations, distributor associations, and trade publications provide context and validate primary research findings.

This commercial intelligence connects to broader FMCG distribution research: many OTC brands are sold by the same distributors who handle personal care, food, and beverage portfolios. For the FMCG-side complement to OTC distribution research, see our Jamaica FMCG Market: Distribution, Pricing and Brands article. For the full distribution audit framework that underpins category-level shelf presence measurement across all FMCG channels, see our Caribbean FMCG distribution audit methodology article.

Sample studies and use cases

OTC and consumer healthcare research applies to commercial questions including:

• Market entry assessment: Sizing the addressable market, identifying competitive intensity, and assessing distribution access before committing to launch.
• Brand health tracking: Quarterly or biannual awareness, trial, repeat, and satisfaction tracking on flagship brands.
• New product launch readiness: Concept testing, pack and naming research, pharmacist receptivity testing, and pricing research before launch.
• Pricing and pack architecture: Conjoint analysis on pack size, format, and price point combinations to optimize commercial returns.
• Trade promotion ROI: Quantifying the consumer-level impact of pharmacy chain promotions, end-cap displays, and pharmacist incentives.
• Switching and category dynamics: Understanding when and why consumers switch brands, packs, or formats.
• Defensive research for incumbents: Tracking competitive entry, vulnerability assessment, and counter-positioning research.

Pricing structure for OTC research projects